Topical tacrolimus for treatment of childhood vitiligo in Asians

Clinical and Experimental Dermatology

Volumn 29, Issue 6, 2004, Pages 589-592

  Kanwar, A J ^a   Dogra, S ^a   Parsad, D ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ARTICLE; ASIAN; BURNING SENSATION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE DURATION; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; FOCAL VITILIGO; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; PRURITUS; REPIGMENTATION; SEGMENTAL VITILIGO; SKIN PIGMENTATION; TOPICAL DRUG ADMINISTRATION; VITILIGO; VITILIGO VULGARIS;

ADMINISTRATION, CUTANEOUS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; OINTMENTS; SKIN PIGMENTATION; TACROLIMUS; TREATMENT OUTCOME; VITILIGO;

EID: 9644252629     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01632.x     Document Type: Article

References (14)

1. Mosher DB, Fitzpatrick TB, Ortonne JP, et al. Hypomelanosis and Hypermelanosis. In: Fitzpatrick, TB, Eisen, AZ, Wolff, K, Freedberg, IM, Austen, KF, eds. Dermatology in General Medicine. New York: McGraw-Hill, 1999: 945-1017.
2. Kanwar AJ, Dhar S, Kaur S. Vitiligo in children. Ind J Dermatol 1993; 38: 47-52.
3. Handa S, Dogra S. Epidemiology of childhood vitiligo. a study of 625 patients from North India. Pediatr Dermatol 2003; 20: 207-10.
4. Mattoo SK, Handa S, Kaur I et al. Psychiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol 2002; 16: 573-8.
5. Njoo MD, Westerhof W, Bos JD, Bossuyt PM. A systematic review of autologous transplantation methods in vitiligo. Arch Dermatol 1998; 134: 1543-9.
6. Cho S, Kang HC, Hahm JH. Characteristics of vitiligo in Korean children. Pediatr Dermatol 2000; 17: 189-93.
7. Njoo MD, Spuls PI, Bos JD et al. Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch Dermatol 1998; 134: 1532-40.
8. Grimes PE, Soriano T, Dytoc MT. Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol 2002; 47: 789-91.
9. Lepe V, Moncada B. Castanedo-Cazares JP et al. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 2003; 139: 581-5.
10. Zabawski EJ, Costner M, Cohen JB, Cockerell CJ. Tacrolimus: pharmacology and therapeutic uses in dermatology. Int J Dermatol 2000; 39: 721-7.
11. Skaehill PA. Tacrolimus in dermatologie disorders. Ann Pharmacother 2001; 35: 582-8.
12. Assmann T, Homey B, Ruzicka T. Topical tacrolimus for the treatment of inflammatory skin diseases. Expert Opin Pharmacother 2001; 2: 1167-75.
13. Reitamo S, Rissanen J, Remitz A et al. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol 1998; 111: 396-8.
14. Plettenberg H, Assmann T, Ruzicka T. Childhood vitiligo and tacrolimus: immunomodulating treatment for an autoimmune disease. Arch Dermatol 2003; 139: 651-4.